-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation
-
Ranibizumab for the treatment of macular edema following retinal vein occlusion
Alex Yuan, Rishi Singh
Review Article: Clinical Investigation